HKU Scholars Hub: Browsing DSpace

Browsing by Author Starr, MD

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 5 to 10 of 10 < previous

	Title	Author(s)	Issue Date	Views
	Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer Journal:Cancer Medicine	Liu, Y Starr, MD Brady, JC Dellinger, A Pang, HMH Adams, B Theuer, CP Lee, NY Hurwitz, HI Nixon, AB	7-Mar-2014	60
	Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 Journal:Molecular Cancer Therapeutics	Liu, Y Starr, MD Brady, JC Rushing, C Pang, H Adams, B Alvarez, D Theuer, CP Hurwitz, HI Nixon, AB	2018	16
	A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine	Uronis, HE Cushman, SM Bendell, JC Blobe, GC Morse, MA Nixon, AB Dellinger, A Starr, MD Li, H Meadows, K Gockerman, J Pang, HMH Hurwitz, HI	2013	82
	A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology	Uronis, HE Jia, J Bendell, J Howard, L Ready, NA Lee, PA Starr, MD Dellinger, A Pang, HMH Nixon, AB	2015	61
	Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance) Journal:Clinical Cancer Research	Nixon, AB Nixon, AB Nixon, AB Pang, HMH Starr, MD Friedman, PN Bertagnolli, MM Kindler, HL Goldberg, RM Venook, AP Hurwitz, HI	2013	48
	Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance) Proceeding/Conference:Journal of Clinical Oncology	Hatch, AJ Pang, HMH Starr, MD Brady, JC Jia, J Chen, J Sibley, A Owzar, K Niedzwiecki, D Venook, AP Cushman, SM Hurwitz, H Nixon, AB	2014	36

Showing results 5 to 10 of 10 < previous